Concepedia

Sarah E. Josefsson

SE

Statistics

Publications

5

Citations

345

H-Index

5

Active since

2017

Affiliations

University of Oslo(Current)

Oslo University Hospital

Karolinska Institutet

Stanford Medicine

Sarah E. Josefsson is an author at University of Oslo specializing in t cell biology, oncology, and cancer immunology.

Publications per year

2017–2023

5

Publications

5

TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

Sarah E. Josefsson, Klaus Beiske, Yngvild Nuvin Blaker et al. · Cancer Immunology Research · 2019 · 115 citations · Full text

, , +17

T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling

Sarah E. Josefsson, Kanutte Huse, Arne Kolstad et al. · Clinical Cancer Research · 2017 · 94 citations · Full text

, , +17

Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma

Hakan Köksal, Pierre Dillard, Sarah E. Josefsson et al. · Blood Advances · 2019 · 62 citations · Full text

, , +16

Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression

Inga Hansine Rye, Kanutte Huse, Sarah E. Josefsson et al. · Molecular Oncology · 2021 · 46 citations · Full text

, , +17

Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma

Ivana Spasevska, Ankush Sharma, Chloé B. Steen et al. · Blood Advances · 2023 · 28 citations · Full text

, , +17

1–5 of 5